Location History:
- Moscow, RU (2002 - 2008)
- Rehovot, IL (2002 - 2012)
Company Filing History:
Years Active: 2002-2012
Title: Mark Boldin: Innovator in Protein Modulation
Introduction
Mark Boldin is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of protein modulation, holding a total of 12 patents. His work focuses on the development of innovative solutions that target specific cellular mechanisms.
Latest Patents
Among his latest patents, Boldin has developed modulators of TNF receptor-associated factor (TRAF). This invention includes a DNA sequence encoding a protein capable of binding to TRAF molecules, along with TRAF-binding proteins, their isoforms, analogs, fragments, and derivatives. The patent also outlines methods for producing these DNA sequences and proteins, as well as their various applications. Another notable patent involves modulators of the function of FAS receptors and other proteins. This invention provides proteins that can modulate the effects of FAS receptor ligands or TNF on cells by interacting with MORT-1 protein, which is crucial for the intracellular signaling of the FAS receptor.
Career Highlights
Mark Boldin is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding of protein interactions and their implications in cellular processes.
Collaborations
Boldin has collaborated with notable colleagues, including David Wallach and Igor Mett. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.
Conclusion
Mark Boldin's contributions to the field of protein modulation are significant and impactful. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and technology.